Arrakis Therapeutics Appoints James Mutamba, PhD, as Chief Business Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. NTSK
10. OLLI

Go back to Arrakis Therapeutics Appoints James Mutamba, PhD, as Chief Business Officer
(NASDAQ: PYXS) Delayed: 3.57 -0.18 (4.8%)
Previous Close $3.75    52 Week High $ 
Open $3.71    52 Week Low $ 
Day High $3.74    P/E N/A 
Day Low $3.45    EPS $ 
Volume 812,185